Semax & Selank Heptapeptides: Comparative Review of BDNF/TrkB Signaling, Enkephalinase Inhibition & Neurochemical Modulation

1. Molecular Design: ACTH(4-7)-Pro-Gly-Pro (Semax) vs Tuftsin-Pro-Gly-Pro (Selank)

Neuropeptides represent an essential class of endogenous central nervous system neuromodulators, but their experimental utility has historically been limited by poor metabolic stability, rapid degradation by blood-brain barrier aminopeptidases, and short plasma half-lives (often measured in seconds).\n\nTo overcome these pharmacokinetic limitations, researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences engineered modified heptapeptides by appending a C-terminal tripeptide proline-glycine-proline (Pro-Gly-Pro / PGP) sequence to endogenous bioactive fragments:\n\n• Semax (Met-Glu-His-Phe-Pro-Gly-Pro, MW 750.8 g/mol): Derived from adrenocorticotropic hormone fragment ACTH(4-10) with the substitution of a PGP C-terminal cap. Crucially, Semax lacks the steroidogenic and hormonal actions of full-length ACTH while amplifying neurotropic and cognitive actions as documented in Human Physiology reviews.\n\n• Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro, MW 751.9 g/mol): Derived by attaching the same PGP tripeptide to the C-terminus of Tuftsin (Thr-Lys-Pro-Arg), an endogenous immunomodulatory tetrapeptide produced in the spleen. This modification grants Selank pronounced anxiolytic and neuromodulatory properties while preserving immune resilience.

• View Semax Product Page
• View Selank Product Page
• Human Physiology: Semax Neurobiology

2. Neurotrophin Induction: Rapid Transcriptional Upregulation of BDNF and TrkB Signaling

The primary molecular mechanism underlying Semax neuroactivity is its rapid induction of Brain-Derived Neurotrophic Factor (BDNF) and its high-affinity receptor, Tropomyosin Receptor Kinase B (TrkB). BDNF is the central neurotrophin responsible for synaptic plasticity, long-term potentiation (LTP), and adult hippocampal neurogenesis.\n\nIn experimental rodent models and neuronal cell cultures published in Molecular Genetics, Microbiology and Virology (PMID 17547124), administration of Semax produced a rapid, dose-dependent upregulation of BDNF mRNA and protein expression in the hippocampus and frontal cortex within 90 minutes of administration. TrkB receptor phosphorylation was elevated concurrently, activating downstream intracellular cascades:\n\n1. Mitogen-Activated Protein Kinase (MAPK/ERK): Promotes neuronal differentiation, dendritic spine branching, and synaptogenesis.\n2. Phosphoinositide 3-Kinase (PI3K/Akt): Suppresses pro-apoptotic caspase cascades and protects cortical neurons from glutamate excitotoxicity and hypoxia.\n3. Phospholipase C-gamma (PLC-gamma): Drives intracellular calcium mobilization and long-term potentiation of synaptic transmission.

Semax stimulates BDNF and Nerve Growth Factor (NGF) synthesis without activating systemic hypothalamic-pituitary-adrenal (HPA) axis hormone release, ensuring localized neurotrophin support without triggering cortisol elevation.

• Mol Gen Mikrobiol Virusol: BDNF Upregulation by Semax
• Inspect Third-Party HPLC Lab Results

3. Neuromodulatory Dynamics: GABAergic Transmission, Serotonin Turnover & Enkephalinase Inhibition

While Semax primarily acts through neurotrophic BDNF cascades, Selank operates primarily as an allosteric neuromodulator of gamma-aminobutyric acid (GABA) neurotransmission and an inhibitor of endogenous enkephalin-degrading enzymes.\n\nElectrophysiological studies published in the Bulletin of Experimental Biology and Medicine (PMID 19803361) demonstrate that Selank selectively modulates GABAA receptors, enhancing inhibitory chloride currents in hippocampal CA1 pyramidal neurons without producing benzodiazepine-like sedation, motor impairment, or downregulatory tolerance.\n\nFurthermore, Selank acts as a competitive inhibitor of neutral endopeptidase (enkephalinase / NEP / CD10) and carboxypeptidase H. By preventing the enzymatic degradation of endogenous leucine-enkephalin and methionine-enkephalin, Selank prolongs natural endorphin signaling, mitigating chronic stress responses and supporting mood stability in laboratory behavioral paradigms.

• Bull Exp Biol Med: Selank GABA Modulation

4. Metabolic Stability & Resistance to Enzymatic Aminopeptidases

The incorporation of the Pro-Gly-Pro (PGP) tripeptide motif at the C-terminus of both Semax and Selank represents a breakthrough in neuropeptide stability engineering. Endogenous neuropeptides are rapidly degraded by carboxypeptidases and post-proline cleaving enzymes.\n\nThe PGP sequence introduces steric hindrance that shields the core peptide backbone from circulating carboxypeptidases and endopeptidases, extending the functional plasma and tissue half-life from seconds to multiple hours in mammalian models.\n\nAdditionally, metabolic breakdown fragments of PGP exhibit secondary anti-inflammatory and tissue-repair actions, preventing vascular micro-thrombosis and supporting cerebral microvascular endothelial integrity.

• View All Reconstitution Tools

5. Lyophilization Integrity, Thermal Degradation & Reconstitution Dynamics

Both Semax and Selank are synthesized as lyophilized freeze-dried cakes sealed under negative pressure in sterile USP Type I glass vials to prevent hydrolytic degradation.\n\nLaboratory Handling Protocol:\n\n• Diluent Choice: Laboratory-grade Bacteriostatic Water (0.9% benzyl alcohol) should be introduced gently along the inner glass vial wall.\n• Temperature Standards: Lyophilized powder vials should be stored at -20°C for long-term stability (up to 24 months). Reconstituted solutions must be refrigerated strictly between 2°C and 8°C and used within 28 days.\n• pH Stability: Both peptides exhibit optimal conformational stability in neutral aqueous solutions (pH 6.5 to 7.4). Avoid exposure to harsh acidic or alkaline solvents that can cause cleavage of the proline-glycine peptide bonds.

• Dosage & Dilution Calculator
• Order Bacteriostatic Water 10ml

6. High-Performance Liquid Chromatography & Mass Spectrometry Purity Standards

At Zora Biolabs, every lot of Semax and Selank undergoes rigorous independent third-party analytical testing to verify scientific purity and identity.\n\nChromatographic Specifications:\n• HPLC Purity: Verified on reversed-phase C18 columns with gradient acetonitrile/water elution containing 0.1% TFA, requiring minimum 99.0% purity with sharp Gaussian peak symmetry.\n• ESI-MS Molecular Confirmation: Electrospray mass spectrometry confirms exact molecular ions [M+H]+ at 751.8 m/z for Semax and [M+H]+ at 752.9 m/z for Selank, confirming sequence integrity and complete protecting group removal.\n• Full Transparency: Batch-specific Certificates of Analysis are publicly searchable on the Zora Biolabs Lab Results repository.

• Browse Verified Zora Biolabs Lab Reports
• View Full Peptides Catalog

References

1. Ashmarin IP, et al. Nootropic analog of ACTH 4-10: Semax (15 years of experience in research and application). Human Physiology, 23(5):572-578 (1997). Source
2. Agapova TV, et al. Effect of Semax on the expression of BDNF and TrkB genes in rat brain after incomplete global transient ischemia. Molecular Genetics, Microbiology and Virology, 22(3):126-131 (2007). Source
3. Uchakina ON, et al. Immunomodulatory activity of Selank in conditions of stress. Bulletin of Experimental Biology and Medicine, 145(4):448-450 (2008). Source
4. Semenova TP, et al. Comparison of the effects of Selank and Semax on the behavioral reactions and neurotransmitter system in rats. Bulletin of Experimental Biology and Medicine, 149(3):300-303 (2010). Source

Related products

• Semax (5mg Vial)
• Selank (10mg Vial)
• Bacteriostatic Water